# Anavex Life Sciences (AVXL) — Earnings

AVXL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/avxl/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2026 |
| Period end | Dec 31, 2025 |
| EPS actual | −$0.06 |
| EPS estimate | −$0.12 |
| EPS surprise | +51.34% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Feb 9, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1314052/000173112226000200/e7289_10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/db922903-72dc-064f-dd3e-45f50a841800.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2026 | Feb 9, 2026 | −$0.12 | −$0.06 | 51.34% | — | — |
| Q4 2025 | Nov 25, 2025 | −$0.15 | −$0.11 | 26.67% | — | — |
| Q3 2025 | Aug 12, 2025 | −$0.14 | −$0.16 | -12.44% | — | — |
| Q2 2025 | May 13, 2025 | −$0.15 | −$0.13 | 13.33% | — | — |
| Q1 2025 | Feb 12, 2025 | −$0.17 | −$0.14 | 17.65% | — | — |
| Q4 2024 | Dec 23, 2024 | −$0.16 | −$0.14 | 14.27% | — | — |
| Q3 2024 | Aug 6, 2024 | −$0.16 | −$0.14 | 12.50% | — | — |
| Q2 2024 | May 9, 2024 | −$0.11 | −$0.13 | -18.18% | — | — |
| Q1 2024 | Feb 7, 2024 | −$0.15 | −$0.11 | 24.14% | — | — |
| Q4 2023 | Nov 27, 2023 | −$0.15 | −$0.12 | 18.20% | — | — |
| Q3 2023 | Aug 8, 2023 | −$0.17 | −$0.14 | 16.02% | — | — |
| Q2 2023 | May 9, 2023 | −$0.19 | −$0.17 | 9.72% | — | — |
| Q1 2023 | Feb 7, 2023 | −$0.19 | −$0.17 | 9.33% | — | — |
| Q4 2022 | Nov 28, 2022 | −$0.17 | −$0.18 | -9.09% | — | — |
| Q3 2022 | Aug 9, 2022 | −$0.15 | −$0.16 | -4.03% | — | — |
| Q2 2022 | May 10, 2022 | −$0.17 | −$0.14 | 16.02% | — | — |
| Q1 2022 | Feb 9, 2022 | −$0.16 | −$0.14 | 9.68% | — | — |
| Q4 2021 | Nov 24, 2021 | −$0.15 | −$0.16 | -9.51% | — | — |
| Q3 2021 | Aug 12, 2021 | −$0.13 | −$0.14 | -4.48% | — | — |
| Q2 2021 | May 13, 2021 | −$0.13 | −$0.12 | 7.69% | — | — |

## Frequently Asked Questions

### When did Anavex Life Sciences (AVXL) last report earnings?

Anavex Life Sciences last reported on Feb 9, 2026, covering fiscal Q1 2026.

### Did AVXL beat earnings estimates?

Yes. Anavex Life Sciences reported EPS of −$0.06 for Q1 2026 against a −$0.12 estimate — a 51.34% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).